Related Experiment Video
Updated: Aug 20, 2025
10:05
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
8.4K
Cardiovascular Pharmacology.
Jessica M Mason1, Michael E O'Brien2, Jennifer L Koehl3
1Department of Pharmacy, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA.
Emergency Medicine Clinics of North America
|November 17, 2022
Summary
This review covers essential pharmacologic therapies for cardiovascular emergencies like acute coronary syndromes, heart failure, and arrhythmias. It offers practical guidance for Emergency Department clinicians managing these critical conditions.
Area of Science:
- Emergency Medicine
- Cardiology
- Clinical Pharmacology
Background:
- Cardiovascular emergencies necessitate prompt and effective pharmacologic interventions.
- Acute coronary syndromes, acute heart failure, and arrhythmias are common critical conditions encountered in emergency settings.
Purpose of the Study:
- To review the pharmacotherapy for key cardiovascular emergencies.
- To provide practical, bedside-applicable insights for Emergency Department (ED) clinicians.
Main Methods:
- Literature review of pharmacologic agents used in cardiovascular emergencies.
- Focus on evidence-based therapies relevant to the ED environment.
Main Results:
- Detailed review of pharmacologic options for acute coronary syndromes.
- Discussion of therapeutic strategies for acute heart failure management.
- Overview of antiarrhythmic drug classes and their application.
Conclusions:
- Pharmacologic therapy is crucial for managing cardiovascular emergencies.
- Practical knowledge of these agents enhances patient care in the ED.
- This review equips clinicians with essential information for bedside decision-making.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.1K
01:29Pathophysiology of Cardiac Performance
766
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
766
01:29Cardiomyopathy V: Interprofessional Care
27
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
64
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
64
01:22Heart Failure Drugs: β-Blockers
413
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
413
01:16Antianginal Drugs: Nitrates and β-Blockers
694
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
694